Adapsyn Bioscience

Making microbes work

Hamilton · Founded 2016

Headquarters
Hamilton
Employees
11–50
Founded
2016
Business Model
B2B
Last Round
Venture RoundJan 2018
Rounds
1

About

Adapsyn Bioscience is a chemical bioinformatics company that discovers and develops novel small molecule therapeutics derived from microbes. Using integrated genomics, metabolomics, and AI platforms, Adapsyn identifies microbial strains that produce novel chemistry, predicts compound structures and drug-likeness, and isolates candidates for drug discovery programs in oncology, infectious disease, and immunology. The company was spun out of McMaster University in 2016 and is backed by Pfizer Ventures, Genesys Capital, the Bill & Melinda Gates Foundation, and Evotec.

Summary

Adapsyn Bioscience is an Artificial Intelligence company based in Hamilton, founded in 2016. Its most recent funding was a Venture Round in Jan 2018. Investors include Pfizer R&D Innovate and Genesys Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundFinancing RoundJan 2018

Investors

Similar Companies

Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
Lila Sciences

Lila Sciences combines artificial intelligence with autonomous laboratories to accelerate scienti...

Cambridge, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.3BJun 2026
OpenAI

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...

San Francisco, United States5001–10000Artificial Intelligence, Generative AI
Corporate RoundTotal funding$179.6BMar 2026
Anthropic

Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...

San Francisco, United States1001–5000Artificial Intelligence, Generative AI
Series G+Total funding$123.7BMay 2026
xAI

xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...

San Francisco, United States201–500Artificial Intelligence, Generative AI
Series ETotal funding$47.4BJan 2026
Waymo

Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...

Mountain View, United States1001–5000Artificial Intelligence, Autonomous Vehicles
Venture RoundTotal funding$29.6BFeb 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Adapsyn Bioscience on Indexed.vc
<a href="https://indexed.vc/companies/adapsyn-bioscience"><img src="https://indexed.vc/api/badge/company/adapsyn-bioscience" alt="Adapsyn Bioscience on Indexed.vc" width="260" height="76" /></a>